Apr 18, 2024
In this episode, host Shikha Jain, MD, speaks
with Jonathan D. Licht, MD, about becoming and
training qualified leaders in the field, challenges facing health
care leaders and more.
• Welcome to another exciting episode of Oncology
Overdrive :58
• About Licht 1:16
• The interview 3:17
• Can you tell us about your journey into
hematology-oncology and how you ended up where you are today?
3:58
• How have you found the time and ability to balance
and succeed in the research, clinical, translational and leadership
parts of your work? 9:05
• What do you suggest to people who are currently
trying to get into leadership positions in their early-to-mid
career? 12:52
• Do you agree with the sentiment that there are some
leaders in the field who are put into positions prematurely or are
ineffective? As a leader, how do you address the need for further
training of future leaders?
18:39
• What are some of the leadership challenges you have
seen in the last several years, and how have you managed to
navigate them? 23:20
• How did you use your leadership skills to navigate
the first few years of the pandemic, and how are you continuing to
navigate delivery of care post-pandemic?
29:23
• Tell me about the process of achieving NCI
designation and what it means for your institution.
36:25
• How have you had to navigate state health care
legislation and policies challenging reproductive health care?
42:16
• If someone could only listen to the last minute of
this episode, what would you want them to take away?
46:13
• How to contact Licht
46:56
• Thanks for listening
48:16
Jonathan D. Licht, MD, is the director of the
University of Florida Health Cancer Center.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com.
Follow Healio on X, formerly known as Twitter, and LinkedIn:
@HemOncToday and
https://www.linkedin.com/company/hemonctoday/.
Follow Dr. Jain on X, formerly known as Twitter:
@ShikhaJainMD. Licht can be reached on X, formerly known as
Twitter, @jdlicht
or via email jdlicht@ufl.edu.
Disclosures: Jain reports no relevant financial
disclosures. Licht reports consultancy for AstraZeneca and research
funding for Epizyme.